# Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prospective-phase-ii-study-of-single-agent-gemcitabine-in-untreated-elderly/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrea Martoni,Francesca Di Fabio,M. Guaraldi,E Piana,R Ramini,G. Lelli,Giuseppe Palomba,Fabrizio Artioli,Elena Bandieri,G. Robustelli della Cuna,P. Preti |
| Citations | 45 |
| DOI | 10.1097/00000421-200112000-00018 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2319466756 |
| PMID | 11801766 |
| Type | article |
| Year | 2001 |

## Paper authors

- [Giuseppe Palomba](https://scholariq.org/researchers/giuseppe-palomba/)

## Paper journal

- [American Journal of Clinical Oncology](https://scholariq.org/journals/american-journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.